2019 IPO

Anchiano Therapeutics

$2.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (1.07%) Today
$0.00 (0.00%) As of 3:59 PM EDT after-hours

Why Robinhood?

You can buy or sell ANCN and other stocks, options, ETFs, and crypto commission-free!

About ANCN

Anchiano Therapeutics Ltd. American Depositary Share, also called Anchiano Therapeutics, is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Read More Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel.

Employees
19
Headquarters
Jerusalem, Jerusalem
Founded
2004
Market Cap
13.67M
Price-Earnings Ratio
Dividend Yield
Average Volume
30.49K
High Today
$2.53
Low Today
$2.32
Open Price
$2.39
Volume
19.20K
52 Week High
$11.50
52 Week Low
$2.15

Collections

2019 IPO

ANCN Earnings

-$0.70
-$0.48
-$0.27
-$0.05
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
-$0.05 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.